5/6 nephrectomy induces different renal, cardiac and vascular consequences in 129/Sv and C57BL/6JRj mice

被引:0
作者
Mouad Hamzaoui
Zoubir Djerada
Valery Brunel
Paul Mulder
Vincent Richard
Jérémy Bellien
Dominique Guerrot
机构
[1] Normandie Univ,Nephrology Department
[2] UNIROUEN,Pharmacology Department
[3] INSERM U1096,Biochemistry Department
[4] FHU REMOD-VHF,Pharmacology Department
[5] Rouen University Hospital,undefined
[6] Reims University Hospital,undefined
[7] Rouen University Hospital,undefined
[8] Rouen University Hospital,undefined
来源
Scientific Reports | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Experimental models of cardiovascular diseases largely depend on the genetic background. Subtotal 5/6 nephrectomy (5/6 Nx) is the most frequently used model of chronic kidney disease (CKD) in rodents. However, in mice, cardiovascular consequences of 5/6 Nx are rarely reported in details and comparative results between strains are scarce. The present study detailed and compared the outcomes of 5/6 Nx in the 2 main strains of mice used in cardiovascular and kidney research, 129/Sv and C57BL/6JRj. Twelve weeks after 5/6 Nx, CKD was demonstrated by a significant increase in plasma creatinine in both 129/Sv and C57BL/6JRj male mice. Polyuria and kidney histological lesions were more pronounced in 129/Sv than in C57BL/6JRj mice. Increase in albuminuria was significant in 129/Sv but not in C57BL/6JRj mice. Both strains exhibited an increase in systolic blood pressure after 8 weeks associated with decreases in cardiac systolic and diastolic function. Heart weight increased significantly only in 129/Sv mice. Endothelium-dependent mesenteric artery relaxation to acetylcholine was altered after 5/6 Nx in C57BL/6JRj mice. Marked reduction of endothelium-dependent vasodilation to increased intraluminal flow was demonstrated in both strains after 5/6 Nx. Cardiovascular and kidney consequences of 5/6 Nx were more pronounced in 129/Sv than in C57BL/6JRj mice.
引用
收藏
相关论文
共 75 条
  • [1] Hill NR(2016)Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis PLOS ONE 11 e0158765-3451
  • [2] Gori M(2014)Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction Eur. Heart J. 35 3442-1305
  • [3] Go AS(2004)Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N. Engl. J. Med. 351 1296-1734
  • [4] Chertow GM(2012)Associations between kidney function and subclinical cardiac abnormalities in CKD J. Am. Soc. Nephrol. JASN 23 1725-3543
  • [5] Fan D(2011)Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc. 26 3537-1594
  • [6] McCulloch CE(2017)Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease Clin. J. Am. Soc. Nephrol. CJASN 12 1588-623
  • [7] Hsu C(2016)Heart failure and kidney dysfunction: epidemiology, mechanisms and management Nat. Rev. Nephrol. 12 610-196
  • [8] Park M(2007)DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains Am. J. Physiol. Renal Physiol. 292 F192-F795
  • [9] Yilmaz MI(2016)Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice Am. J. Physiol. Renal Physiol. 310 F785-1137
  • [10] Kopel T(2017)Local CD34-positive capillaries decrease in mouse models of kidney disease associating with the severity of glomerular and tubulointerstitial lesions BMC Nephrol. 18 280-1117